These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8289)
21. Metabolism and choleretic effect of naltrexone in the isolated perfused rat liver. Rodgers RM; Taylor SM; Dickinson RG; Ilias AM; Lynn RK; Gerber N Drug Metab Dispos; 1980; 8(6):390-6. PubMed ID: 6109606 [TBL] [Abstract][Full Text] [Related]
22. A 3-O-methylated catechol metabolite of diphenylhydantoin (Dilantin) in rat urine. Chang T; Okerholm RA; Glazko AJ Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):13-23. PubMed ID: 4671868 [No Abstract] [Full Text] [Related]
23. Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver. Lynn RK; Garvie-Gould C; Milam DF; Scott KF; Eastman CL; Rodgers RM Drug Metab Dispos; 1983; 11(2):109-14. PubMed ID: 6133713 [TBL] [Abstract][Full Text] [Related]
24. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat. El-Hawari AM; Plaa GL J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136 [TBL] [Abstract][Full Text] [Related]
25. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine. Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000 [No Abstract] [Full Text] [Related]
26. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver. Sallustio BC; Fairchild BA; Shanahan K; Evans AM; Nation RL Drug Metab Dispos; 1996 Sep; 24(9):984-9. PubMed ID: 8886608 [TBL] [Abstract][Full Text] [Related]
27. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man. Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326 [TBL] [Abstract][Full Text] [Related]
28. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile. Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254 [TBL] [Abstract][Full Text] [Related]
29. Absolute configurations of the dihydrodiol metabolites of 5,5-diphenylhydantoin (phenytoin) from rat, dog, and human urine. Maguire JH; Butler TC; Dudley KH Drug Metab Dispos; 1980; 8(5):325-31. PubMed ID: 6107230 [TBL] [Abstract][Full Text] [Related]
30. A comparison of diphenylhydantoin metabolism in different tissues using high performance liquid chromatography. MacKinney AA; Shinnick FL; Gorder C Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):395-411. PubMed ID: 7122986 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of ethyl apovincaminate in the rat. Vereczkey L; Szporny L Arzneimittelforschung; 1976; 26(10a):1933-8. PubMed ID: 1037219 [TBL] [Abstract][Full Text] [Related]
33. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin. Billings RE J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524 [TBL] [Abstract][Full Text] [Related]
34. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog. Butler TC; Dudley KH; Johnson D; Roberts SB J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486 [TBL] [Abstract][Full Text] [Related]
35. Identification of 2-methyl-1,4-naphthohydroguinone monoglucuronide as a metabolite of 2-methyl-1,4-naphthoquinone (menadione) in rat bile. Thompson RM; Gerber N; Seibert RA; Desiderio DM Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):543-52. PubMed ID: 4638592 [No Abstract] [Full Text] [Related]
36. Meperidine metabolites: identification of N-hydroxynormeperidine and a hydroxy-methoxy derivative of meperidine in biological fluids. Stillwell WG; Myran CS; Stewart JT Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):605-19. PubMed ID: 986679 [TBL] [Abstract][Full Text] [Related]
37. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. Morris ME; Yuen V; Tang BK; Pang KS J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309 [TBL] [Abstract][Full Text] [Related]
38. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851 [TBL] [Abstract][Full Text] [Related]
39. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite. Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277 [TBL] [Abstract][Full Text] [Related]
40. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates. Jackson CJ; Hubbard JW; McKay G; Cooper JK; Hawes EM; Midha KK Drug Metab Dispos; 1991; 19(1):188-93. PubMed ID: 1673397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]